Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03652103
Other study ID # ESPforPNL
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date September 5, 2018
Est. completion date March 15, 2019

Study information

Verified date April 2021
Source Bozyaka Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigators' goal is to determine whether Erector Spinae Plane Block would provide a better analgesia, help mobilization and early discharge or increase satisfaction for patients undergoing Percutaneous Nephrolithotomy(PNL). One of the two groups will receive ESP catheterization after general anesthesia conducted. The other group will receive routine analgesia protocol used for PNL. The total amount of drugs administered, pain scores(NRS) at certain time intervals and at certain events(removal of nephrostomy and pain at mobilization) will be recorded and compared.


Description:

Erector Spinae Plane Block(ESP) is a rather new method which can block ventral and dorsal rami of spinal nerves in the paravertebral area after they leave the spinal column. Originally used for thoracic somites, by spreading in a craniocaudal fashion in the erector spinae muscle group, it has the potential of blocking cervical or lumbar nerves as well. To provide better analgesia for surgical procedures, anesthesiologists use truncal blocks for peripheral intervention. Although these blocks are generally very effective and easy to apply, they are limited by a relatively small area of effectivity. In order to achieve denser effects for larger surfaces, epidural anesthesia must be used with the risk of more severe complications than any peripheral or truncal nerve blocks. Epidural anesthesia also has the disadvantages of requiring more experience and more cautiousness than ultrasound-guided truncal blocks and risks of an undesirable temporary motor blockade. ESP block could be the answer for better regional analgesia while avoiding motor blockade and complications of epidural anesthesia. The study will have two groups as Block Group(GB) and Control Group(GC) and two periods as during operation and 48 hours after the operation. Every participant will receive Total Intravenous Anesthesia(TIVA) and will be monitored with ECG, non-invasive blood pressure, heart rate, pulse oximeter, and Bispectral Index. Participants in GB will receive ultrasound-guided ESP block catheter after proper maintenance of anesthesia provided. The first period will be during operation. We will evaluate the administered drug amounts per kilogram for each patient. Investigators believe ESP block will help them deliver proper anesthesia with lower dosages. The second period will include postoperative 48 hours. Pain scores(NRS) will be evaluated at certain time intervals and at two critical moments between the two groups. One of the critical moment which patients fear and feel the pain most is the removal time of nephrostomy. The second moment is the first time patients start walking. Rescue analgesia will be ordered on demand for both groups as IV 1 mg/kg tramadol. Hours and amounts of rescue analgesia administered will be recorded.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date March 15, 2019
Est. primary completion date March 10, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients who are scheduled for percutaneous nephrolithotomy under total intravenous anesthesia - Patients who has informed consent for study - Patients with American Society of Anesthesiologists Physical Status Classification(ASA) I and II Exclusion Criteria: - Patient's refusal to participate - Patients under 18 years of age - Patients who are undergoing surgery with an anesthesia technique other than total intravenous anesthesia for any reason (inhalation anesthesia, laryngeal mask application, etc.) - Patients with known local anesthetic allergy - Patients with Body mass index > 35 - Patients diagnosed sepsis and bacteriemia, - Skin infection at the injection site, - Patients with previous spinal surgery - History of coagulopathy or anticoagulant therapy - Patients with uncontrolled diabetes , - Uncoordinated patients, - Psychological and emotional lability, - Surgical intervention longer than 3 hours.

Study Design


Intervention

Procedure:
Ultrasound Guided Erector Spinae Plane Block Catheterisation
After receiving general anesthesia, patients will positioned prone. Before operation begins, ESP block catheter will be applied with ultrasound guidance to the same level as surgeon's incision.
Drug:
Bupivacaine 0.25% Injectable Solution
Perineural Injection

Locations

Country Name City State
Turkey Izmir Bozyaka Training and Research Hospital Karabaglar Izmir

Sponsors (1)

Lead Sponsor Collaborator
Bozyaka Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dosage of Drugs Amounts of drugs per kilogram per hour will be recorded During procedure
Primary Post-operative pain assessed by Numeric Rating Scale (NRS) Pain scores will be recorded as reported by the patient according to NRS 30th minute postoperatively
Primary Post-operative pain assessed by Numeric Rating Scale (NRS) Pain scores will be recorded as reported by the patient according to NRS 60th minute postoperatively
Primary Post-operative pain assessed by Numeric Rating Scale (NRS) Pain scores will be recorded as reported by the patient according to NRS 2nd hour postoperatively
Primary Post-operative pain assessed by Numeric Rating Scale (NRS) Pain scores will be recorded as reported by the patient according to NRS 6th hour postoperatively
Primary Post-operative pain assessed by Numeric Rating Scale (NRS) Pain scores will be recorded as reported by the patient according to NRS 12th hour postoperatively
Primary Post-operative pain assessed by Numeric Rating Scale (NRS) Pain scores will be recorded as reported by the patient according to NRS 24th hour postoperatively
Primary Post-operative pain assessed by Numeric Rating Scale (NRS) Pain scores will be recorded as reported by the patient according to NRS 48th hour postoperatively
Primary Post-operative pain assessed by Numeric Rating Scale (NRS) Pain scores will be recorded during the first steps as reported by the patient according to NRS Mobilisation at postoperative day (POD) 1
Primary Post-operative pain assessed by Numeric Rating Scale (NRS) Pain scores will be recorded during the procedure as reported by the patient according to NRS At the time of removal of nephrostomy at postoperative day (POD) 2
Secondary Opioid Consumption Opioids(Tramadol) will be administered to patients in case demanded. 48 hour post-operatively
Secondary Discharge Day of the discharge 240 hours post-operatively
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2
Completed NCT04551196 - Management of Post-Tonsillectomy Pain in Pediatric Patients Phase 3